Search

Your search keyword '"Ilboudo, Hamidou"' showing total 223 results

Search Constraints

Start Over You searched for: Author "Ilboudo, Hamidou" Remove constraint Author: "Ilboudo, Hamidou"
223 results on '"Ilboudo, Hamidou"'

Search Results

1. Enhanced effect of seasonal malaria chemoprevention when coupled with nutrients supplementation for preventing malaria in children under 5 years old in Burkina Faso: a randomized open label trial

6. Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a protocol for a randomized open label trial

7. Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol

8. Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea.

9. OA-765 Molecular diagnostic tests specificities and their contribution for HAT postelimination monitoring in Burkina Faso and Côte d’Ivoire

10. PA-730 Impact of additional screening using highly-sensitive rapid diagnostic tests and treatment combined with monthly Sulfadoxine-Pyrimethamine on LBW and peripheral malaria infection: asser malaria study

12. Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)

13. Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?

14. Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso

15. Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso

16. Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis

19. Performance of clinical signs and symptoms, rapid and laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a non-interventional, prospective cross-sectional study

20. Molecular diagnosis of Plasmodium falciparum in three active foci of human African trypanosomiasis (Boffa, Dubreka and Forecariah) in Guinea

21. Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis

22. Diversity of response to Trypanosoma brucei gambiense infections in the Forecariah mangrove focus (Guinea): perspectives for a better control of sleeping sickness

23. Free-ranging pigs identified as a multi-reservoir of Trypanosoma brucei and Trypanosoma congolense in the Vavoua area, a historical sleeping sickness focus of Côte d’Ivoire

24. Extravascular dermal trypanosomes in suspected and confirmed cases of gambiense Human African Trypanosomiasis

25. HLA-G 3’UTR 14 bp Insertion Is Associated with a Decreased Risk of Developing Human African Trypanosomiasis in the Côte d’Ivoire Population

26. Des trypanosomes dans la peau

27. Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with Vitamin A, Zinc and Plumpy’DozTM to prevent malaria and malnutrition in children under five years old in Burkina Faso: a randomized open label trial (SMC-NUT)

29. Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso

30. A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire

31. Analytical sensitivity of loopamp and quantitative real-time PCR on dried blood spots and their potential role in monitoring human African trypanosomiasis elimination

32. High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation

33. Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis

35. PS-003: EVIDENCE-INFORMED POLICY MAKING: CHALLENGES AND OPPORTUNITIES

36. Macrophage migrating inhibitory factor expression is associated with Trypanosoma brucei gambiense infection and is controlled by trans-acting expression quantitative trait loci in the Guinean population

37. Do cryptic reservoirs threaten gambiense-sleeping sickness elimination?

38. PO 8441 EXPERIMENTAL COMPARISON OF SENSITIVITY OF LAMP AND REAL-TIME PCR

40. A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations

41. Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis

42. The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Cote d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense

43. Copy number variation in human genomes from three major ethno-linguistic groups in Africa.

45. Differences in pathogenicity and virulence of Trypanosoma brucei gambiense field isolates in experimentally infected Balb/C mice

46. Description of the first sleeping sickness case diagnosed in Burkina Faso since two decades

47. Ebola outbreak brings to light an unforeseen impact of tsetse control on sleeping sickness transmission in Guinea

48. The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense

49. T cell activation and the HLA locus associate with latent infections of human African trypanosomiasis

50. APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis

Catalog

Books, media, physical & digital resources